First Command Advisory Services’s Genmab GMAB Stock Holding History

First Command Advisory Services’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18K	Buy	+43	New	+$1.14K	﹤0.01%	1098

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

First Command Advisory Services's GMAB Position: Q2 2026 in Review

First Command Advisory Services opened a new position in Genmab (GMAB) in Q2 2026: 43 shares worth $1.18K. The stake represents ﹤0.01% of the portfolio and ranks #1098 among its holdings.

289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

First Command Advisory Services held 43 shares of Genmab worth $1.18K as of Q2 2026.
Genmab was a new First Command Advisory Services position in Q2 2026.
Genmab made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #1098 holding.
289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.